| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |